The Bronchodilator Drugs market in Puerto Rico is anticipated to witness a significant growth in revenue, with projections indicating that it will reach a staggering US$10.15m by 2024. This ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Dexedrine spansule capsules are formulated to release the active drug substance in vivo in ... systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence that clearly ...

Seretide/Advair (fluticasone+ salmeterol) - a drug from GlaxoSmithKline with Sales of US$ Billion 7.1 in 2007. Salmeterol xinafoate is a bronchodilator which relaxes the muscles in the walls of ...

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

Bitolterol(Tornalate) generic is a bronchodilator, prescribed for the relief of bronchospasm due to asthma and other respiratory diseases. It works by relaxing muscles in the airways to improve ...